The administration of therapeutic cell types, such as stem and progenitor cells, has gained
much interest for the limitation or repair of tissue damage caused by a variety of insults …

Background Cardiac cell transplantation is compromised by low cell retention and poor graft
viability. Here, the effects of co-injecting adipose tissue-derived stem cells (ASCs) with …

Background Recent studies have demonstrated that transplantation of adipose-derived stem
cell (ADSC) can improve cardiac function in animal models of myocardial infarction (MI) …

Various tissue resident stem cells are receiving tremendous attention from basic scientists
and clinicians and hold great promise for myocardial regeneration. For practical reasons …

The aim of the study was to determine the long-term effect of transplantation of adipose-
derived stromal cells (ADSCs) in a preclinical model of ischemia/reperfusion (I/R). I/R was …

Aims We assessed whether freshly isolated human adipose tissue-derived cells (fhADCs) or
cultured human adipose tissue-derived stem cells (hASCs) have beneficial effects on …

Myocardial infarction caused by vascular occlusion results in the formation of nonfunctional
fibrous tissue. Cumulative evidence indicates that cell therapy modestly improves cardiac …

Treatment of myocardial infarction (MI) with bone marrow-derived mesenchymal stem cells
and recently also adipose-derived stem cells has shown promising results. In contrast to …

Background Autologous adipose tissue–derived mesenchymal stem cells (ATMSC s)
therapy is a promising strategy to improve post–myocardial infarction outcomes. In a porcine …

Stem cell therapy is a promising tool to improve outcome after acute myocardial infarction
(AMI), but needs to be optimized since results from clinical applications remain ambiguous …